Discussing the Impact of the Pandemic on the Management of Lung,
Breast, Gastrointestinal and Genitourinary Cancers — Part 4:
Interview with Dr Oh on the following topics:
Management of genitourinary cancers during the COVID-19 era
(00:00)
Case (Dr Oh): A man in his early 80s with
metastatic castration-resistant prostate cancer tests positive for
SARs-CoV-2 (17:03)
Case (Dr Oh): A man in his early 70s is
diagnosed with metastatic renal cell carcinoma amid the COVID-19
pandemic (18:50)
Risk factors for complications from COVID-19; emerging
mechanism for the protective effects of androgen deprivation
therapy (20:20)
Impact of the pandemic on the care of patients with
genitourinary cancers (26:20)
Effects of COVID-19 on the care of patients with cancer and on
cancer research (37:00)
New advances and emerging options for the management of
COVID-19 (45:17)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.